HOLLYWOOD, FL – November 18, 2025 – Ibogaine By David Dardashti, a globally recognized leader in psychedelic-assisted therapies, today announced the five-year anniversary of the strategic integration of its specialized Ibogaine “reflection” treatment protocol. Following five years of meticulous data collection and patient monitoring, the clinic reports significant long-term success improvements for patients utilizing this smaller, follow-up ...

Playa del Carmen, Mexico – June 24, 2025 – Ibogaine by David Dardashti, a globally recognized leader in ibogaine treatment, proudly announces the grand opening of its second state-of-the-art clinic in the serene coastal city of Playa del Carmen, Mexico. This significant expansion is a direct response to the escalating demand for comprehensive ibogaine-assisted therapies and ...

MIAMI, FL – June 20, 2025 – Ibogaine by David Dardashti, a pioneering leader in ibogaine-assisted therapy and led by visionary David Dardashti, today announced a groundbreaking collaboration with a Psychedelic University. This strategic partnership aims to establish robust internship opportunities for students passionate about contributing to the rapidly evolving psychedelic field, with initial networking prospects ...

DENVER, CO – June 19, 2025 – Ibogaine by David Dardashti, a leading initiative in ibogaine research and advocacy, today commenced its participation in the highly anticipated Psychedelic Science Conference 2025 in Denver, Colorado. As the conference officially began its main programming today, June 18th, the presence of Ibogaine by David Dardashti marks a pivotal moment ...

DENVER, CO – May 21, 2025 – Ibogaine By David Dardashti, will be hosting a booth at the upcoming Psychedelic Science 2025 conference, hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS). The conference, a premier global gathering for psychedelic research, medicine, policy, and culture, will take place from June 16-20, 2025, at the Colorado Convention ...